Legacy Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEGACY PHARMA, and what generic and branded alternatives to LEGACY PHARMA drugs are available?
LEGACY PHARMA has seven approved drugs.
Drugs and US Patents for Legacy Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Legacy Pharma | BETAPACE AF | sotalol hydrochloride | TABLET;ORAL | 021151-001 | Feb 22, 2000 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | CAPSULE;ORAL | 021447-003 | Aug 29, 2002 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | TABLET;ORAL | 020397-002 | Feb 4, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Legacy Pharma | BETAPACE | sotalol hydrochloride | TABLET;ORAL | 019865-001 | Oct 30, 1992 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | CAPSULE;ORAL | 021447-002 | Aug 29, 2002 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma | BETAPACE AF | sotalol hydrochloride | TABLET;ORAL | 021151-002 | Feb 22, 2000 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Legacy Pharma | BETAPACE AF | sotalol hydrochloride | TABLET;ORAL | 021151-006 | Apr 2, 2003 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Legacy Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | CAPSULE;ORAL | 021447-001 | Aug 29, 2002 | 6,455,557 | ⤷ Sign Up |
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | CAPSULE;ORAL | 021447-003 | Aug 29, 2002 | 6,455,557 | ⤷ Sign Up |
Legacy Pharma Usa | ZANAFLEX | tizanidine hydrochloride | CAPSULE;ORAL | 021447-002 | Aug 29, 2002 | 6,455,557 | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for LEGACY PHARMA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Capsules | 2 mg, 4 mg and 6 mg | ➤ Subscribe | 2007-08-10 |
Similar Applicant Names
Here is a list of applicants with similar names.